Warning: include(/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Core/Router.php): Failed to open stream: No such file or directory in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(): Failed opening '/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Core/Router.php' for inclusion (include_path='.:/opt/alt/php82/usr/share/pear:/opt/alt/php82/usr/share/php:/usr/share/pear:/usr/share/php') in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Controllers/ReportController.php): Failed to open stream: No such file or directory in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(): Failed opening '/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Controllers/ReportController.php' for inclusion (include_path='.:/opt/alt/php82/usr/share/pear:/opt/alt/php82/usr/share/php:/usr/share/pear:/usr/share/php') in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Core/DB.php): Failed to open stream: No such file or directory in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(): Failed opening '/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Core/DB.php' for inclusion (include_path='.:/opt/alt/php82/usr/share/pear:/opt/alt/php82/usr/share/php:/usr/share/pear:/usr/share/php') in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Core/View.php): Failed to open stream: No such file or directory in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(): Failed opening '/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Core/View.php' for inclusion (include_path='.:/opt/alt/php82/usr/share/pear:/opt/alt/php82/usr/share/php:/usr/share/pear:/usr/share/php') in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571
Intelligence Archive // China Watch

Warning: include(/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Services/AuthService.php): Failed to open stream: No such file or directory in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571

Warning: include(): Failed opening '/home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/../../core/src/Services/AuthService.php' for inclusion (include_path='.:/opt/alt/php82/usr/share/pear:/opt/alt/php82/usr/share/php:/usr/share/pear:/usr/share/php') in /home/u542596555/domains/chinawatch.blog/public_html/vendor/composer/ClassLoader.php on line 571
Login

Research Library

// Global Analysis Archive

Sort By

Per Page

DISPLAYING 1-1 OF 1 RECORDS — TAGGED "Multinational Pharma"

PAGE 1 / 1

China Biotech Mar 29, 2026

China Biotech Outlicensing Surges to Record as Multinationals Chase Innovative Drug Pipelines

According to the source, Chinese biotech firms’ cross-border outlicensing reached a record US$60 billion in Q1 2026, up 73% year on year. The surge highlights growing multinational appetite for China-origin innovative drug candidates and a deepening integration of China’s biotech sector into global pharma dealmaking.

RPT-3252 • 0 views ACCESS »

China Biotech Outlicensing Surges to Record as Multinationals Chase Innovative Drug Pipelines

According to the source, Chinese biotech firms’ cross-border outlicensing reached a record US$60 billion in Q1 2026, up 73% year on year. The surge highlights growing multinational appetite for China-origin innovative drug candidates and a deepening integration of China’s biotech sector into global pharma dealmaking.

Mar 29, 2026 0 views

ID	Title	Category	Date	Views
RPT-3252	China Biotech Outlicensing Surges to Record as Multinationals Chase Innovative Drug Pipelines	China Biotech	2026-03-29	0	ACCESS »

Go to:

Page 1 of 1 • 1 total reports